American Portfolios Advisors’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-50
Closed -$4.85K 2962
2019
Q3
$4.85K Hold
50
﹤0.01% 2209
2019
Q2
$5.12K Hold
50
﹤0.01% 2179
2019
Q1
$5.69K Sell
50
-425
-89% -$31.2K ﹤0.01% 2044
2018
Q4
$18.6K Buy
475
+50
+12% +$2.17K ﹤0.01% 1405
2018
Q3
$23.2K Buy
425
+25
+6% +$1.71K ﹤0.01% 1434
2018
Q2
$33.1K Buy
400
+150
+60% +$11.6K ﹤0.01% 1247
2018
Q1
$16.6K Hold
250
﹤0.01% 1444
2017
Q4
$12.9K Buy
+250
New +$18K ﹤0.01% 1491

American Portfolios Advisors's ONCE Position: Q4 2019 in Review

American Portfolios Advisors sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 50 shares — an estimated $4.85K sold.

American Portfolios Advisors first reported a position in ONCE in Q4 2017 and held it in 8 quarters. The position peaked at $33.1K in Q2 2018. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • American Portfolios Advisors reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • American Portfolios Advisors sold 50 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $4.85K.
  • American Portfolios Advisors first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2017 and held it in 8 quarters.
  • American Portfolios Advisors's Spark Therapeutics, Inc. Common Stock position peaked at $33.1K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on American Portfolios Advisors's 13F filing for Q4 2019, filed 24 Mar 2023.